Proteomics Market Was Valued at USD 20,869.2 million in 2021, the growth is attributed to the increase in demand for personalized medicines.

According to Precision Business Insights (PBI) latest report the global proteomics market is expected to be worth USD 22,538.7 million in 2022, growing at 12.5% CAGR from 2022 to 2028. Global Proteomics Market is segmented into the following types: by technology (Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance), by Component (Reagents & Kits, Instruments, Software & Services), Application (Research Applications, Clinical Applications), End-Users (Pharmaceutical & Biotechnology, Academic & Research Institutes, Diagnostic Laboratories, Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) Forecast to 2028. Key player's profiles in the Proteomics market report are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., Waters Corporation. The rise in popularity of personalised medicine, an increase in R&D spending, and technological improvements related to proteomics components are all driving market expansion for proteomic market. However, the market's growth is hampered by high component prices and a scarcity of trained personnel. On the other hand, attractive potential related with biomarker identification and improvements in mass spectrometry-based proteomics are projected to drive the proteomics industry forward. Players are focusing on innovation and launching new products for the growth of market. For instance, in 2017, Diagenode, a provider of complete solutions for epigenetics research and sample preparation, in collaboration with PreOmics GmbH, developer and provider of innovative tools for MS-based proteomics, launched new streamlined sample preparation solution for proteomic analyses. The new solution was developed by combining PreOmics in-StageTip Kit (iST Kit) and the Diagenode Bioruptor sonication system to clean peptides for mass spectrometry (MS) analysis.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-proteomics-market/

Microarray Segments are Dominate the Proteomics Market
Based on the technology protein microarray segment generated the highest revenue in 2021 owing to its wide variety of applications including the identification of protein-protein interactions, protein-phospholipid interactions, small molecule targets, and substrates of proteins kinases. Protein microarrays can screen for reactivity to hundreds to many thousands of unique autoantigens simultaneously on a single chip using minimal serum input. Considering these benefits microarray segment is anticipated to grow the highest revenue in the forecasting year

North America Leads Proteomics Market:
North America accounted to have a significant share of the global proteomics market and the market is expected to grow at a significant CAGR over the forecast years due to increased investments in the development of structure-based drug design, burgeoning omics research, a rising need for high-quality research tools for data reproducibility, and a growing focus on producing individualized therapies. The presence of a high number of global companies in this area also contributes to the market's expansion. Asia-Pacific is expected to grow the market owing to the rise in the prevalence of chronic diseases and expansion of business by the market players into the region
Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players

Global Proteomics market further reveals that the key players increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In January 2021 Thermo Fisher Scientific acquired technological solutions company Phitonex Inc. developers of a spectral dye platform for high-resolution biology applications.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16780

The Proteomics market detailed segmentation:
Based on the Technology, the market is segmented into the following:
• Protein Microarrays
• Spectroscopy
• X-ray Crystallography
• Chromatography
• Electrophoresis
• Surface Plasmon Resonance

Based on the Component, the market is segmented into the following:
• Reagents & Kits
• Instruments
• Software & Services

Based on the application, the market is segmented into the following:
• Research Applications
• Clinical Applications

Based on the end user, the market is segmented into the following:
• Pharmaceutical & Biotechnology
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.